Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05652101

Hyperekplexia : Adaptative Skills and Neurodevelopmental Trajectory

Conditions: Hyperekplexia

Sex: All
Ages: 2 Years – N/A
Enrollment: 40
Sponsor: Hospices Civils de Lyon

Location: France

Summary

Hereditary hyperekplexia is a rare neuronal disorder, caused by genetic defects leading to dysfunction of glycinergic neurotransmission.The clinical presentation is characterized by stiffness and exaggerated startle responses to unexpected stimuli, that appear shortly after birth.The generalised stiffness can lead to apnea and sudden infant death syndrome.Several genes are known to be associated with hereditary hyperekplexia. The most frequent are Glycine Receptor Alpha 1 (GLRA1), Glycine Receptor Beta (GLRB) and Solute Carrier Family 6 Member 5 (SLC6A5). They encode for the postsynaptic glycine receptor (GLRA1, GLRB) and the presynaptic glycine transport (SLC6A5). Genetic mutations in these genes lead to dysfunction in the glycinergic inhibitory neurotransmission.The neurodevelopment was initially described as normal, or as delayed due to the motor difficulties. Global development delay and intellectual disability are reported as well, in the most recent studies.Nevertheless, the degree of severity of the learning difficulties and the adaptive faculties of the patients is not specified.Similarly, the efficacy of clonazepam in hyperekplexia is well known, but the evolution of dosage over time and the frequency of complete withdrawal have never been studied.The primary endpoint of this study is to describe adaptive skills using a standardized questionnaire, Vineland Adaptive Behavior Scale (VABS2).Secondary endpoints are:Neurodevelopmental course studyDescription of the evolution of the clinical manifestations over the yearsEvaluation of the efficacity of the treatment CLONAZEPAM, initially and over time, and evolution of the dosageComparison of clinical and therapeutical characteristics according to the genotype

Eligibility Criteria

Inclusion Criteria:Clinical diagnostic criteria for hyperekplexia (see Thomas et al. BRAIN, 2013):The presence of hypertonia (either hypertonia on examination, axial or segmental, or access of stiffness)Exaggerated reflex startles, to auditory, tactile or visual stimuliThe presence of reflex bursts on percussion of the midlineChildren >2 years and adultsNo opposition of one of the two parents (or legal representative) or of the adult patientExclusion Criteria:The presence of a cause secondary to the hyperekplexia (traumatic, autoimmune, etc.)The presence of another cause for a delay in psychomotor development (other neurological pathology, serious head trauma, etc.)Pregnant or breastfeeding womenPerson deprived of liberty by judicial or administrative decision

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05652101). StuddyBuddy aggregates publicly available trial information.